These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 416322)

  • 1. Metabolic effects of clofibrate in insulin-dependent ketosis-prone diabetic man.
    Schade DS; Eaton RP; George S; Conway M; Kaminsky N; Sivinski J
    Metabolism; 1978 Apr; 27(4):461-8. PubMed ID: 416322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of fatty acid metabolism by glucagon in man. III. Role of pharmacologic limitation of FFA availability.
    Schade DS; Eaton RP
    Diabetes; 1975 Nov; 24(11):1020-6. PubMed ID: 1183732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of glucagon and other hormones in development of diabetic ketoacidosis.
    Alberti KG
    Lancet; 1975 Jun; 1(7920):1307-11. PubMed ID: 49515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of plasma ketone body concentration by counter-regulatory hormones in man. II. Effects of growth hormone in diabetic man.
    Schade DS; Eaton RP; Peake GT
    Diabetes; 1978 Sep; 27(9):916-24. PubMed ID: 689302
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment.
    Tiengo A; Muggeo M; Assan R; Fedele D; Crepaldi G
    Metabolism; 1975 Aug; 24(8):901-14. PubMed ID: 1143089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute insulin deficiency on glucose and ketone body turnover in man: evidence for the primacy of overproduction of glucose and ketone bodies in the genesis of diabetic ketoacidosis.
    Miles JM; Rizza RA; Haymond MW; Gerich JE
    Diabetes; 1980 Nov; 29(11):926-30. PubMed ID: 6775996
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of short term physiological elevations of plasma glucagon concentration on plasma triglyceride concentration in normal and diabetic man.
    Schade DS; Eaton RP
    Horm Metab Res; 1977 Jul; 9(4):253-7. PubMed ID: 892688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic response to norepinephrine in normal versus diabetic man.
    Schade DS; Eaton RP
    Diabetologia; 1978 Dec; 15(6):433-9. PubMed ID: 720776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of clofibrate on plasma glucose, lipoproteins, fibrinogen, and other biochemical and haematological variables in patients with mature onset diabetes mellitus.
    Calvert GD; Blight L; Franklin J; Oliver J; Wise P; Gallus AS
    Eur J Clin Pharmacol; 1980 May; 17(5):355-62. PubMed ID: 6998709
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin receptors on monocytes from patients with ketosis-prone diabetes mellitus.
    Pedersen O; Beck-Nielsen H; Heding L
    Diabetes; 1978 Nov; 27(11):1098-104. PubMed ID: 102554
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose response to insulin in man: differential effects on glucose and ketone body regulation.
    Schade DS; Eaton RP
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1038-53. PubMed ID: 874043
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucagon regulation of plasma ketone body concentration in human diabetes.
    Schade DS; Eaton RP
    J Clin Invest; 1975 Nov; 56(5):1340-4. PubMed ID: 1184755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased glucose disappearance rate after short-term clofibrate administration in normal subjects and in patients with chemical diabetes.
    Ferrari C; Testori GP; Bertazzoni A; Romussi M; Caldara R; Frezzati S
    Horm Metab Res; 1978 Jan; 10(1):4-6. PubMed ID: 631736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabetics.
    Schade DS; Eaton RP
    Diabetes; 1975 May; 24(5):510-5. PubMed ID: 805077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis.
    Burge MR; Garcia N; Qualls CR; Schade DS
    Metabolism; 2001 Feb; 50(2):171-7. PubMed ID: 11229425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulation of plasma ketone body concentration by counterregulatory hormones in man.
    Schade DS; Eaton RP
    Diabetes; 1977 Oct; 26(10):989-96. PubMed ID: 908465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive effects of octreotide (SMS 201-995) on diabetic ketogenesis during insulin withdrawal.
    Diem P; Robertson RP
    Br J Clin Pharmacol; 1991 Nov; 32(5):563-7. PubMed ID: 1954071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon.
    Gerich JE; Lorenzi M; Bier DM; Schneider V; Tsalikian E; Karam JH; Forsham PH
    N Engl J Med; 1975 May; 292(19):985-9. PubMed ID: 804137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in man.
    Eaton RP; Schade DS
    Metabolism; 1974 May; 23(5):445-54. PubMed ID: 4825301
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical characterization of ketosis-resistant young diabetics of northern India. In vivo effects of i.v. glucose, s.c. epinephrine and i.v. glucagon and in vitro effects of anti-insulin serum on adipose tissue lipolysis.
    Krishna Ram B; Sachdev G; Chopra A; Karmarkar MG
    Acta Diabetol Lat; 1984; 21(2):141-51. PubMed ID: 6433609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.